SonarMD

SonarMD, a leading whole-health solution for patients with gut health conditions, is transforming what it means to live with inflammatory bowel disease (Crohn’s and ulcerative colitis), diverticulitis, GERD, and irritable bowel syndrome. SonarMD was founded by Dr. Lawrence Kosinski, a gastroenterologist since 1984, who recognized that specialists are uniquely positioned to take greater accountability for patients living with chronic disease. SonarMD is led by Beth Houck and Julie Schokora, our CEO and COO respectively, who have a combined 45 years of healthcare industry experience and a track record of success developing and operating patient-focused solutions. By focusing on building technology that engages patients around their symptoms and predicts the deterioration of clinical status, SonarMD enables specialists to limit the morbidity associated with chronic disease. SonarMD has been proven to keep chronic GI patients healthier, more productive, and reduces annual medical costs by $6,500 per member per year, according to a peer-reviewed study with Blue Cross & Blue Shield of Illinois. Today, SonarMD serves as a trusted extension of the clinical/care management team for physician groups and health plans nationwide.